Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 7,920 | 8,726 | 8,849 | 11,048 | 7,160 |
| Operating Income | -7,920 | -8,726 | -8,849 | -11,048 | -7,160 |
| Other Income | 759 | 1,832 | 4,943 | 1,130 | -234 |
| Pre-tax Income | -7,161 | -6,894 | -3,906 | -9,918 | -7,394 |
| Income Tax | 95 | N/A | 43 | 7 | 47 |
| Net Income Continuous | -7,256 | -6,894 | -3,949 | -9,925 | -7,441 |
| Net Income | $-7,256 | $-6,894 | $-3,949 | $-9,925 | $-7,441 |
| EPS Basic Total Ops | -0.10 | -0.09 | -0.05 | -0.14 | -0.12 |
| EPS Basic Continuous Ops | -0.10 | -0.09 | -0.05 | -0.14 | -0.12 |
| EPS Diluted Total Ops | -0.10 | -0.09 | -0.05 | -0.14 | -0.12 |
| EPS Diluted Continuous Ops | -0.10 | -0.09 | -0.05 | -0.14 | -0.12 |
| EBITDA(a) | $-7,822 | $-8,603 | $-8,742 | $-10,945 | $-7,064 |